Atlas Trials

Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

Clinical trial NCT03411967 · UNKNOWN

Trial details

NCT number
NCT03411967
Sponsor
Zigong No.1 Peoples Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2018-02-01
Primary completion
2020-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.